American Healthcare REIT shares are under pressure as the market re-prices the risk of incremental share issuance tied to the company’s newly established ATM equity offering program. The program, set up on February 27, 2026, authorizes sales of up to $1.75 billion of common stock and includes the flexibility to use forward sale agreements—mechanics that can increase effective supply and cap near-term upside when investors expect the company to tap equity for capital needs. (sec.gov)

ATM programs can weigh on REIT stocks even without a single, headline-grabbing overnight offering because shares may be sold into normal trading volume over time. With AHR’s authorization size at $1.75 billion, investors are treating the facility as a meaningful overhang and are watching for updates on actual issuance volumes and share-count changes in upcoming filings and quarterly results. (sec.gov)

Separately, AHR recently updated its debt financing terms, including an amendment that increased its senior unsecured revolving credit facility to $800 million (from $600 million) and referenced aggregate borrowing capacity of $1.35 billion as of April 1, 2026. While added liquidity can be supportive, the combination of expanded funding tools (debt capacity plus a large ATM) is keeping investor focus on capital-raising strategy, leverage targets, and potential dilution. (m.investing.com)

Key swing factors are whether AHR is actively issuing shares under the ATM (and at what pace), any updates to forward-sale settlements, and management commentary on how proceeds would be allocated (deleveraging vs. acquisitions). Investors will also be monitoring timing around the company’s next results cycle and any new guidance or portfolio transactions that could change the perceived need for equity issuance. (ir.americanhealthcarereit.com)